| Kristin Cohen, CNM | |
|
225 Williamson St, Elizabeth, NJ 07202-3625 | |
| (908) 994-5000 | |
| Not Available |
| Full Name | Kristin Cohen |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 225 Williamson St, Elizabeth, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184393951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 25ME00076001 (New Jersey) | Primary |
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922018514 PECOS PAC ID: 9830003417 Enrollment ID: O20041026000021 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.
"Over the next few weeks, appropriators will be engaged in the challenging task of evaluating U.S. foreign assistance funding, including how effectively Congress' global health investments are being used," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation; Molly Joel Coye, interim president and CEO of PATH; Carolyn Miles, president and CEO of Save the Children; and Richard Stearns, president of World Vision, write in this Roll Call opinion piece.
The news story made a big splash: in January 2016 ETH researchers Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty published a study in the journal Nature Nanotechnology about an innovative type of membrane developed in their laboratory.
› Verified 3 days ago
| Entity Name | Trinitas Physicians Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205189941 PECOS PAC ID: 6709002850 Enrollment ID: O20140725000027 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.
"Over the next few weeks, appropriators will be engaged in the challenging task of evaluating U.S. foreign assistance funding, including how effectively Congress' global health investments are being used," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation; Molly Joel Coye, interim president and CEO of PATH; Carolyn Miles, president and CEO of Save the Children; and Richard Stearns, president of World Vision, write in this Roll Call opinion piece.
The news story made a big splash: in January 2016 ETH researchers Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty published a study in the journal Nature Nanotechnology about an innovative type of membrane developed in their laboratory.
› Verified 3 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.
"Over the next few weeks, appropriators will be engaged in the challenging task of evaluating U.S. foreign assistance funding, including how effectively Congress' global health investments are being used," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation; Molly Joel Coye, interim president and CEO of PATH; Carolyn Miles, president and CEO of Save the Children; and Richard Stearns, president of World Vision, write in this Roll Call opinion piece.
The news story made a big splash: in January 2016 ETH researchers Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty published a study in the journal Nature Nanotechnology about an innovative type of membrane developed in their laboratory.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Cohen, CNM 32 Hillcrest Ave, Cranford, NJ 07016-2673 Ph: () - | Kristin Cohen, CNM 225 Williamson St, Elizabeth, NJ 07202-3625 Ph: (908) 994-5000 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.
"Over the next few weeks, appropriators will be engaged in the challenging task of evaluating U.S. foreign assistance funding, including how effectively Congress' global health investments are being used," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation; Molly Joel Coye, interim president and CEO of PATH; Carolyn Miles, president and CEO of Save the Children; and Richard Stearns, president of World Vision, write in this Roll Call opinion piece.
The news story made a big splash: in January 2016 ETH researchers Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty published a study in the journal Nature Nanotechnology about an innovative type of membrane developed in their laboratory.
› Verified 3 days ago
Nahid Afraz, CM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 65 Jefferson Ave, Elizabeth, NJ 07201 Phone: 908-994-5500 | |
Martin Eitel, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 225 Williamson St, Elizabeth, NJ 07202 Phone: 908-994-5197 Fax: 908-994-5742 | |
Mehri Jaraha, CM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 225 Williamson St, Elizabeth, NJ 07202 Phone: 908-994-5197 Fax: 908-994-5742 |